| Tocilizumab in the treatment of adult rheumatoid arthritis R Sanmartí, V Ruiz-Esquide, C Bastida, D Soy Immunotherapy 10 (6), 447-464, 2018 | 29 | 2018 |
| Polypharmacy and potential drug-drug interactions in an HIV-infected elderly population C Bastida, A Grau, M Márquez, M Tuset, E De Lazzari, E Martínez, ... Farmacia Hospitalaria 41 (5), 618-624, 2017 | 29 | 2017 |
| Rhabdomyolysis and severe hepatotoxicity due to a drug-drug interaction between ritonavir and simvastatin. Could we use the most cost-effective statin in all human … C Bastida, MA Also, JM Pericas, E Letang, M Tuset, JM Miró Enfermedades Infecciosas y Microbiología Clínica 32 (9), 579-582, 2014 | 25* | 2014 |
| Is there potential for therapeutic drug monitoring of biologic agents in rheumatoid arthritis? C Bastida, V Ruíz, M Pascal, J Yagüe, R Sanmartí, D Soy British journal of clinical pharmacology 83 (5), 962-975, 2017 | 19 | 2017 |
| Fixed dosing of intravenous tocilizumab in rheumatoid arthritis. Results from a population pharmacokinetic analysis C Bastida, V Ruiz‐Esquide, M Pascal, AHM de Vries Schultink, J Yagüe, ... British Journal of Clinical Pharmacology 84 (4), 716-725, 2018 | 17 | 2018 |
| Stability of frozen 1% voriconazole ophthalmic solution P Amorós-Reboredo, C Bastida-Fernandez, L Guerrero-Molina, ... American Journal of Health-System Pharmacy 72 (6), 479-482, 2015 | 17 | 2015 |
| Meropenem population pharmacokinetics in patients with decompensated cirrhosis and severe infections C Bastida, M Hernández-Tejero, F Aziz, C Espinosa, M Sanz, M Brunet, ... Journal of Antimicrobial Chemotherapy 75 (12), 3619-3624, 2020 | 14 | 2020 |
| Polifarmacia e interacciones farmacológicas potenciales en una población envejecida con infección por el VIH C Bastida, A Grau, M Márquez, M Tuset, E De Lazzari, E Martínez, ... Farmacia Hospitalaria 41 (5), 618-624, 2017 | 14 | 2017 |
| Exposure‐response modeling of tocilizumab in rheumatoid arthritis using continuous composite measures and their individual components C Bastida, D Soy, V Ruiz‐Esquide, R Sanmartí, ADR Huitema British journal of clinical pharmacology 85 (8), 1710-1718, 2019 | 11 | 2019 |
| Use and safety of denosumab in cancer patients A Manzaneque, C Chaguaceda, M Mensa, C Bastida, N Creus-Baró International Journal of Clinical Pharmacy 39, 522-526, 2017 | 11 | 2017 |
| Desensitization to rituximab in a multidisciplinary setting P Amorós-Reboredo, J Sánchez-López, C Bastida-Fernández, ... International journal of clinical pharmacy 37, 744-748, 2015 | 11 | 2015 |
| Tigecycline population pharmacokinetics in critically ill patients with decompensated cirrhosis and severe infections C Bastida, M Hernández-Tejero, M Cariqueo, F Aziz, V Fortuna, M Sanz, ... Journal of Antimicrobial Chemotherapy 77 (5), 1365-1371, 2022 | 9 | 2022 |
| Once-daily 1 g ceftriaxone optimizes exposure in patients with septic shock and hypoalbuminemia receiving continuous veno-venous hemodiafiltration M Ulldemolins, C Bastida, M Llauradó-Serra, C Csajka, A Rodríguez, ... European Journal of Clinical Pharmacology 77, 1169-1180, 2021 | 7 | 2021 |
| The effectiveness and tolerability of imiquimod suppositories to treat extensive intra-anal high-grade squamous intraepithelial lesions/warts in HIV-infected individuals I Fuertes, C Bastida, C Lopez-Cabezas, L Rodríguez-Carunchio, J Ordi, ... International journal of STD & AIDS 30 (12), 1194-1200, 2019 | 7 | 2019 |
| Evaluation of dose-tapering strategies for intravenous tocilizumab in rheumatoid arthritis patients using model-based pharmacokinetic/pharmacodynamic simulations C Bastida, ADR Huitema, MJ l’Ami, V Ruiz-Esquide, GJ Wolbink, ... European journal of clinical pharmacology 76, 1417-1425, 2020 | 6 | 2020 |
| Anticoagulation in atrial fibrillation: NOAC prescribing in primary health care C Bastida, N Corominas, JM Sotoca, M Rovira International Journal of Clinical Pharmacy, 1-5, 2017 | 5 | 2017 |
| The safety of antimicrobials for the treatment of community-acquired pneumonia C Bastida, D Soy, A Torres Expert Opinion on Drug Safety 19 (5), 577-587, 2020 | 3 | 2020 |
| Predictive performance of glomerular filtration rate equations based on cystatin C, creatinine and their combination in critically ill patients M Albanell-Fernández, C Bastida, ÁM Fendian, J Mercadal, ... European Journal of Hospital Pharmacy, 2023 | 1 | 2023 |
| Creatine kinase elevation in autosomal dominant polycystic kidney disease patients on tolvaptan treatment D Rodríguez-Espinosa, JJ Broseta, C Bastida, MI Álvarez-Mora, ... Nephron 147 (3-4), 152-157, 2023 | 1 | 2023 |
| Is there a potential for therapeutic drug monitoring of subcutaneously administered tocilizumab in patients with rheumatoid arthritis in daily practice? Z Layegh, F Hooijberg, C Bastida, ADR Huitema, T Rispens, CG Wolbink Clinical and experimental rheumatology 40 (3), 664-665, 2021 | 1 | 2021 |
